Drugs Consultative Committee | The Health Master

Home Tags Drugs Consultative Committee

Industry

Cosmetic Labels: DCC suggests BIS Standards

The Health Master -

October 7, 2024

Industry

Boosting Drug Regulatory Efficiency: DCC recommends for Training and Development

The Health Master -

October 4, 2024

Nation

DCC: A Call for Safe and Responsible Drug Disposal

The Health Master -

September 30, 2024

Industry

DCC recommends amendment of Rules to curbing Antimicrobial Resistance

The Health Master -

September 23, 2024

Industry

DCC recommends closely monitoring quality of Eye Drops

The Health Master -

September 20, 2024

Nation

DCC recommends to address drug Brand Name Confusion in India

The Health Master -

September 17, 2024

Industry

Draft guidelines issued for Good Distribution Practices for Pharmaceuticals

The Health Master -

August 13, 2024

Industry

Drug Export NOCs Now Handled by CDSCO

The Health Master -

May 3, 2024

Industry

DCC: Take action to Curb Antimicrobial Resistance (AMR) in India

The Health Master -

April 23, 2024

Health and Fitness

DCC Approves Ban on Harmful Antibiotics in Food Products

The Health Master -

April 16, 2024

Industry

DCC: Sub-committee to look into one-time NOC for exports

The Health Master -

April 15, 2024

Medical Store Pharmacy Medicine Pharmacist

Pharmacy education / Medical Store

New Regulations for Competent Persons in Charge of Homoeopathy Wholesalers

The Health Master -

April 11, 2024

Industry

DCC: All states to provide data on Vaccine

The Health Master -

April 3, 2024

Jan Vishwas Act

Industry

Altered Provisions: Jan Vishwas (Provisions Amendment) Act, 2023

The Health Master -

April 2, 2024

Industry

DCC to set deadline for adding details on Sugam portal

The Health Master -

April 1, 2024

Industry

Revised Schedule M: The Role of Pharmaceutical Waste Management

The Health Master -

March 27, 2024

Industry

DCC: Insights from the Drugs Consultative Committee on NSQ Drugs

The Health Master -

March 21, 2024

Industry

Shaping the Future of Drug Testing and Regulation: DCC

The Health Master -

December 11, 2023

Industry

Uniform Guidelines for Drug Inspectors’ Arrest Powers: DCC

The Health Master -

December 11, 2023

Industry

New Amendments to Section 32B of the Drugs and Cosmetics Act, 1940

The Health Master -

December 6, 2023

Industry

The Crucial Role of Responsible Person in Pharma: DCC

The Health Master -

December 4, 2023

Nation

Investigation into Tapentadol and Pregabalin: DCC recommendation

The Health Master -

December 2, 2023

Nation

DCC recommends SLAs to submit Adverse Drug Reaction

The Health Master -

November 29, 2023

Nation

The Urgent Need for a Unified System in Drug Safety: DCC

The Health Master -

November 28, 2023

12 Page 1 of 2

Archives

Authors

138 POSTS0 COMMENTS

40 POSTS0 COMMENTS

40 POSTS0 COMMENTS

20 POSTS0 COMMENTS

13 POSTS0 COMMENTS

Dr. Kumud Madan

13 POSTS0 COMMENTS

11 POSTS0 COMMENTS

Sushant Mahapatra

9 POSTS0 COMMENTS

Dr. Bharatesh R Jagashetty

7 POSTS0 COMMENTS

5 POSTS0 COMMENTS

5 POSTS0 COMMENTS

Manmohan Taneja

5 POSTS0 COMMENTS

Dr. Brahmdeep Sindhu

4 POSTS0 COMMENTS

4 POSTS0 COMMENTS

3 POSTS0 COMMENTS

http://www.pharmastute.com

3 POSTS0 COMMENTS

2 POSTS0 COMMENTS

Dr. P K Sreekumar

2 POSTS0 COMMENTS

1 POSTS0 COMMENTS

1 POSTS0 COMMENTS

1 POSTS0 COMMENTS

Sanjay Malhotra

1 POSTS0 COMMENTS

http://www.aerolgroup.com

1 POSTS0 COMMENTS

Dr. Balraj Yadav

1 POSTS0 COMMENTS

Dr. Gulshan Rai Arora

1 POSTS0 COMMENTS

Prof Vivek Padgaonkar

1 POSTS0 COMMENTS

https://www.linkedin.com/in/vivek-padgaonkar-8298509/